Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Journal Article

Mensch, Alexander ORCID: 0000-0003-0089-4473, Beck, Tanja, Civello, Daniele ORCID: 0000-0001-7905-3292, Kunigkeit, Christopher, Lachmann, Nicole, Stock, Stephanie ORCID: 0000-0002-1726-9300, Gandjour, Afschin and Mueller, Dirk (2018). Applying GRADE Criteria to Clinical Inputs to Cost-Effectiveness Modeling Studies. Pharmacoeconomics, 36 (8). S. 987 - 995. NORTHCOTE: ADIS INT LTD. ISSN 1179-2027

Mensch, Alexander, Stock, Stephanie, Stollenwerk, Bjoern and Mueller, Dirk (2015). Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation. Pharmacoeconomics, 33 (3). S. 271 - 284. NORTHCOTE: ADIS INT LTD. ISSN 1179-2027

Mensch, Alexander, Stock, Stephanie, Stollenwerk, Bjoern and Mueller, Dirk (2015). Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation. Pharmacoeconomics, 33 (3). S. 271 - 284. NORTHCOTE: ADIS INT LTD. ISSN 1179-2027

Mueller, Dirk, Fischer, Kirsten, Kaiser, Peter, Eichhorst, Barbara, Walshe, Ronald, Reiser, Marcel, Kellermann, Lenka, Borsi, Lisa, Civello, Daniele, Mensch, Alexander, Bahlo, Jasmin, Hallek, Michael, Stock, Stephanie and Fingerle-Rowson, Guenter (2016). Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Leuk. Lymphoma, 57 (5). S. 1130 - 1140. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

This list was generated on Fri Mar 29 16:13:37 2024 CET.